Chronic gastritis: diagnostics and treatment


Cite item

Full Text

Abstract

Chronic gastritis (CG) is one of the most prevalent diseases of gastrointestinal tract, which is asymptomatic in the large share of the patients. The main etiologic factor of CG is microorganism Helicobacter pylori, which persistence in gastric mucosa can cause the consequential development of chronic active inflammation, atrophy, metaplasia, metaplasi and in some cases - gastric cancer. Other forms of gastritis (autoimmune, chemical, lymphocytic and other) are rare. Treatment of CG includes the elimination of etiological factor, and if it is unknown, - on the main stages of pathogenesis and decreasing of disease symptoms. In in treatment of CG associated with Helicobacter pylori, it is preferably to use four component scheme. Therapy of other form comes down to symptoms decreasing.

References

  1. Graham DY, Genta RM, Dixon MF. Gastritis. Philadelphia: Lippincott Williams & Wilkins; 1999.
  2. Аруин Л.И., Григорьев П.Я., Исаков В.А. и др. Хронический гастрит. Амстердам, 1993. 362 с.
  3. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
  4. Hocker M, Hohenberger P. Helicobacter pylori virulence factors - one part of a big picture. Lancet 2003;362:1231-33.
  5. Dixon MF, Genta R, Yardley J, et al. Classification and grading of gastritis. Am J Surg Pathol 1996;20(10):1161-81.
  6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992;52:6735-40.
  7. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-89.
  8. Talley NJ, Vakil N, Ballard ED, et al. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999;341:1106-11.
  9. Голофеевский В.Ю., Павлович И.М. Хронический атрофический гастрит, ассоциированный с инфекцией H. pylori, как предопухолевая патология желудка (современное состояние вопроса) // Гастроэнтерология Санкт-Петербурга. 2005. № 3-4. С. 44-47.
  10. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2 - 2000 Consensus Report. Aliment Pharmacol Ther 2002;16(2):167-80.
  11. Yakovenko E, Grigoriev P, Yakovenko A, et al. Bismuth-based regimes should be first line therapy for Helicobacter pylori eradication. Gut 2002;51:(Suppl. 1:11):A92.
  12. Toh BH, Van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997;337:1441-48.
  13. Lynch DA, Dixon MF, Axon AT. Diagnostic criteria in lymphocytic gastritis. Gastroenterology 1997;112:1426-7.
  14. Ectors NL, Dixon MF, Geboes KJ, et al. Granulomatous gastritis: a morphological and diagnostic approach. Histopathology 1993;23:55-61.
  15. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2296&mid=1085056570&magid=172&full=1

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies